163 related articles for article (PubMed ID: 28894270)
1. A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.
Rodrigo JP; Villaronga MÁ; Menéndez ST; Hermida-Prado F; Quer M; Vilaseca I; Allonca E; Pedregal Mallo D; Astudillo A; García-Pedrero JM
Sci Rep; 2017 Sep; 7(1):11110. PubMed ID: 28894270
[TBL] [Abstract][Full Text] [Related]
2. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; González MV; Mancebo G; Fresno MF; García-Pedrero J
Mol Cancer; 2010 Mar; 9():48. PubMed ID: 20196862
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
5. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy.
Rodrigo JP; Álvarez-Alija G; Menéndez ST; Mancebo G; Allonca E; García-Carracedo D; Fresno MF; Suárez C; García-Pedrero JM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1333-41. PubMed ID: 21646305
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in laryngeal dysplasia: a systematic review.
Nankivell P; Weller M; McConkey C; Paleri V; Mehanna H
Head Neck; 2011 Aug; 33(8):1170-6. PubMed ID: 21755560
[TBL] [Abstract][Full Text] [Related]
7. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
[TBL] [Abstract][Full Text] [Related]
8. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.
Villaronga MÁ; Hermida-Prado F; Granda-Díaz R; Menéndez ST; Álvarez-Teijeiro S; Quer M; Vilaseca I; Allonca E; Garzón-Arango M; Sanz-Moreno V; Astudillo A; Rodrigo JP; García-Pedrero JM
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):805-813. PubMed ID: 29654156
[No Abstract] [Full Text] [Related]
10. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A
Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403
[TBL] [Abstract][Full Text] [Related]
11. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
12. The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
[TBL] [Abstract][Full Text] [Related]
13. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
Zhang XW; Liu N; Chen S; Wang Y; Zhang ZX; Sun YY; Qiu GB; Fu WN
Diagn Pathol; 2015 Apr; 10():22. PubMed ID: 25879432
[TBL] [Abstract][Full Text] [Related]
14. The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions.
Granda-Díaz R; Menéndez ST; Pedregal Mallo D; Hermida-Prado F; Rodríguez R; Suárez-Fernández L; Vallina A; Sánchez-Canteli M; Rodríguez A; Fernández-García MS; Rodrigo JP; García-Pedrero JM
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30823625
[TBL] [Abstract][Full Text] [Related]
15. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
[TBL] [Abstract][Full Text] [Related]
16. Biological and clinical significance of p75NTR expression in laryngeal squamous epithelia and laryngocarcinoma.
Li X; Shen Y; Di B; Li J; Geng J; Lu X; He Z
Acta Otolaryngol; 2012 Mar; 132(3):314-24. PubMed ID: 22201277
[TBL] [Abstract][Full Text] [Related]
17. [The expression of CD44 and it's significance in human laryngeal carcinoma].
Zhao S; Sun B; He J; Ye Q; Lin S; Sun A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Mar; 17(3):164-6. PubMed ID: 12815898
[TBL] [Abstract][Full Text] [Related]
18. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.
de Vicente JC; Rodríguez-Santamarta T; Rodrigo JP; Allonca E; Vallina A; Singhania A; Donate-Pérez Del Molino P; García-Pedrero JM
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484317
[TBL] [Abstract][Full Text] [Related]
20. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
